Wedgewood Partners JNJ trades
David Rolfe
David Rolfe Johnson & Johnson stake
total: 97
Trades details
- Total transactions:
- 14
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 7
- Held since:
- 2016 Q1
- Held for:
- 30 quarters
- Latest activity:
- 2023 Q3
According to 2026 Q2 report, David Rolfe doesn't hold any Johnson & Johnson (JNJ) shares. To date, the estimated cost basis is nearly $118.91 for "buy" trades and estimated average "sell" price is $165.03. Wedgewood Partners first purchased JNJ in 2016 Q1, initially acquiring 5,250 shares. Since the initial investment in Johnson & Johnson (JNJ), Wedgewood Partners has made 13 more transactions.
When did David Rolfe sell Johnson & Johnson (JNJ)?
David Rolfe sold off the entire Johnson & Johnson (JNJ) position in 2023 Q3.
When did David Rolfe buy Johnson & Johnson (JNJ)?
David Rolfe first invested in Johnson & Johnson (JNJ) in 2016 Q1 at the reported quarter-end price of $108.19 per share.
What's the cost basis of Wedgewood Partners's JNJ stake?
The estimated cost basis for Johnson & Johnson (JNJ) stake is around $118.91 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $118.91
- Weighted AVG sell price:
- $165.03
David Rolfe's historical trades in Johnson & Johnson
14 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q3
|
0.00%
|
0
|
$165.34
|
|
-100% (-4,905)
|
-0.13%
|
|
2023 Q2
|
0.13%
|
4,905
|
$165.34
|
$811,000
|
+0.62% (+30)
|
+0%
|
|
2023 Q1
|
0.13%
|
4,875
|
$154.87
|
$755,000
|
-13.33% (-750)
|
-0.02%
|
|
2022 Q4
|
0.18%
|
5,625
|
$176.53
|
$993,000
|
-12.11% (-775)
|
-0.03%
|
|
2022 Q3
|
0.20%
|
6,400
|
$163.28
|
$1,045,000
|
-0.78% (-50)
|
-0%
|
|
2022 Q1
|
0.16%
|
6,450
|
$177.21
|
$1,143,000
|
+12.66% (+725)
|
+0.02%
|
|
2021 Q4
|
0.13%
|
5,725
|
$171.00
|
$979,000
|
-6.53% (-400)
|
-0.01%
|
|
2021 Q3
|
0.14%
|
6,125
|
$161.47
|
$989,000
|
-0.02% (-1)
|
-0%
|
|
2021 Q2
|
0.15%
|
6,126
|
$164.71
|
$1,009,000
|
-2.76% (-174)
|
-0%
|
|
2018 Q3
|
0.04%
|
$138.10
|
+4.13% (+250)
|
|||
|
2018 Q2
|
0.04%
|
$121.32
|
+9.01% (+500)
|
|||
|
2017 Q4
|
0.03%
|
$139.64
|
-3.48% (-200)
|
|||
|
2017 Q2
|
0.02%
|
$132.17
|
+9.52% (+500)
|
|||
|
2016 Q1
|
0.01%
|
$108.19
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.